New shot tested to help moms with dangerous pregnancy condition
NCT ID NCT07282171
Summary
This early-stage study is testing a new injection called CBP-4888 in pregnant women hospitalized with preterm preeclampsia, a serious blood pressure condition. The main goal is to find a safe and tolerable dose and to understand how the drug moves through the body. Participants will receive one injection along with their standard hospital care and will be followed closely, along with their babies, for safety.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PREECLAMPSIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Royal Melbourne
RECRUITINGMelbourne, Australia
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
The Royal Women's Hospital
RECRUITINGParkville, Victoria, 3052, Australia
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.